(Medical Xpress)—The University of Delaware's Prasad Dhurjati is a chemical engineer whose background includes systems engineering, biotechnology and artificial intelligence. Yet recently, he has been investigating autism ...
Mar 5, 2013
2
0
Melbourne researchers have developed cows' milk that protects human cells from HIV.
Oct 17, 2012
0
0
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
Oct 11, 2012
0
0
A team led by a physician-scientist at the University of Southern California (USC) has created an experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally ...
Jul 17, 2012
0
0
Moderna plans to have 100 to 125 million doses of its COVID-19 vaccine available in the first quarter of 2021, the vast majority of which will go to the United States, the biotechnology company announced Thursday.
Dec 4, 2020
0
2
The email that arrived in the ancient German city of Mainz shortly before 1 a.m. in the morning marked a turning point in the global effort to deliver a reliable vaccine against the coronavirus pandemic—and for the little-known ...
Dec 2, 2020
0
2
Cash-strapped Latin American governments face severe geographical, economic and social challenges in trying to ensure life-saving COVID-19 vaccines are made available to vulnerable populations, experts say.
Nov 26, 2020
0
3
Given the global urgency of the COVID-19 pandemic, Microsoft's AI for Health program has stepped in to support the development and potential deployment of Vaxine's COVAX-19 vaccine with a philanthropic grant.
Aug 24, 2020
0
10
Juno Therapeutics and its CEO, Hans E. Bishop, are being named in a lawsuit over whether the biotechnology company misled investors about the death of a patient in a key study involving its drug intended to treat leukemia.
Jul 13, 2016
0
0
A study of an experimental treatment for leukemia was abruptly halted this week following two patient deaths, raising questions about a closely-watched approach to cancer that involves reprogramming cells to seek and destroy ...
Jul 8, 2016
0
0
